Ucrest Bhd
KLSE:UCREST
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
MY |
U
|
Ucrest Bhd
KLSE:UCREST
|
89m MYR | 14 | |
US |
Veeva Systems Inc
NYSE:VEEV
|
29.6B USD | 53.3 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 47.3 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | -116.8 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
13.1B AUD | 188.6 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 24.2 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.5B USD | 37.3 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.7B USD | -297.5 | ||
SE |
Sectra AB
STO:SECT B
|
46.5B SEK | 109.6 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
3.2B USD | -487.3 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | -324 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.